about
How citation distortions create unfounded authority: analysis of a citation networkSporadic inclusion body myositis: the genetic contributions to the pathogenesis.Effects of nonsteroidal anti-inflammatory drugs on amyloid-beta pathology in mouse skeletal muscle.Calpain inhibition attenuates intracellular changes in muscle cells in response to extracellular inflammatory stimulation.Proteomic study of sporadic inclusion body myositis.Ongoing developments in sporadic inclusion body myositisMitochondrial oxygen consumption deficits in skeletal muscle isolated from an Alzheimer's disease-relevant murine modelPartial tandem duplication of mtDNA-tRNA(Phe) impairs mtDNA translation in late-onset mitochondrial myopathyMitochondrial dysfunction in skeletal muscle of amyloid precursor protein-overexpressing mice.Mitochondrial and inflammatory changes in sporadic inclusion body myositisIn inclusion-body myositis muscle fibers Parkinson-associated DJ-1 is increased and oxidized.Inclusion-body myositis: muscle-fiber molecular pathology and possible pathogenic significance of its similarity to Alzheimer's and Parkinson's disease brains.Mitochondrial dysfunction in myofibrillar myopathy.Widespread RNA metabolism impairment in sporadic inclusion body myositis TDP43-proteinopathy.Novel therapeutic approaches for inclusion body myositis.Association study reveals novel risk loci for sporadic inclusion body myositis.Mitochondrial Lon protease is a human stress protein.Muscle biopsies from human muscle diseases with myopathic pathology reveal common alterations in mitochondrial function.Complex mitochondrial DNA rearrangements in individual cells from patients with sporadic inclusion body myositis.Chaperone-mediated autophagy components are upregulated in sporadic inclusion-body myositis muscle fibres.ANT1 is reduced in sporadic inclusion body myositis.Expression of DJ-1 in Neurodegenerative Disorders.Anti-aminoacyl-tRNA synthetase-related myositis and dermatomyositis: clues for differential diagnosis on muscle biopsy.Inflammatory Myopathy in Horses With Chronic Piroplasmosis.
P2860
Q24260685-C4EFDCB5-A6AA-45BF-B785-6111FE96BE25Q33806912-11D4C92B-3F55-4C8F-B51A-8E1EA334CCB0Q34020429-5D70A5B9-2360-4A12-A1CD-688B8B653708Q34175815-45A3D813-F7C2-4F51-8B77-73FCADE0AC82Q34234305-54918344-DE9E-46BD-8A69-4D80F17A0580Q34519540-BB4567A0-7E57-4EA1-B1F4-C9DF62C0861EQ35093852-8238BD8C-9632-4130-8124-ABDB886BABE7Q35906544-335F35ED-D50C-43A2-85A9-8D9FF0BBFC03Q36016957-79E96E08-A2F5-430D-8071-5FE5024DF9DCQ36802198-50477F44-CF99-4BA1-976A-CC178E2E23EEQ36963892-B79B6916-3514-4AEA-8DF2-CC57F44F04B7Q37083992-2A59F7CE-B1BF-4144-B19A-05E07B113EB1Q37343276-BDF18432-5049-4CCD-9B05-723A9E4C17DFQ37706412-8B120E73-7EA9-4626-BAE7-0A6DE89F11BDQ37786521-2371A50E-1DCF-4072-927C-DB0D2978DFD8Q38944635-6E9EE31C-51A7-4998-ACA7-AF3F5CE56344Q39852098-CB1B8C2B-242A-471A-A8CD-8762C4016D56Q39888514-F054CD44-7CF6-4EA2-8B3C-C5C6E1570184Q42578650-D2A44572-8B43-46C4-8EF3-7907DEACFA7EQ45328567-F2DDF094-2D1F-4FB1-8434-5B699B3E7BEBQ45735393-4DA6A034-498A-45AF-BAB7-6842BD639540Q47393162-52A56E64-627D-4402-8E9D-F9F8FD30E8B4Q48285249-D672C5E1-916A-4B79-851B-F42A0EF191F5Q52572936-09DD9371-07CF-44E4-8038-2449A5D43CF3
P2860
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
Mitochondrial abnormalities in inclusion-body myositis.
@ast
Mitochondrial abnormalities in inclusion-body myositis.
@en
type
label
Mitochondrial abnormalities in inclusion-body myositis.
@ast
Mitochondrial abnormalities in inclusion-body myositis.
@en
prefLabel
Mitochondrial abnormalities in inclusion-body myositis.
@ast
Mitochondrial abnormalities in inclusion-body myositis.
@en
P2093
P1433
P1476
Mitochondrial abnormalities in inclusion-body myositis.
@en
P2093
P304
P356
10.1212/01.WNL.0000192127.63013.8D
P407
P433
P577
2006-01-01T00:00:00Z